|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00986713 |
|
Date of registration:
|
29/09/2009 |
|
Primary sponsor: |
|
|
Public title:
|
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
June 2008 |
|
Target sample size:
|
400 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00986713 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Bin Cao, doctor |
|
Address:
|
|
|
Telephone:
|
8610-85231130 |
|
Email:
|
caobin1999@gmail.com |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- 65ys=age=18ys
- renal transplant recipients
Exclusion Criteria:
- subjects with hypersensitivity to amphotericin B
- receipt of inhalational or intravenous amphotericin B within last 30 days
- subjects with known invasive fungal infection before renal transplant
- subjects with pneumonia
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Invasive Pulmonary Aspergillosis
|
|
Intervention(s)
|
|
Drug: Amphotericin B
|
|
Primary Outcome(s)
|
|
invasive pulmonary aspergillosis
[Time Frame: 3 years]
|
|
Secondary ID(s)
|
|
CYH-CMU AmB Neph
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|